Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: Results of a controlled prospective randomized clinical trial

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1469-1473

  Sporbeck, Birte ^a   Mathiske Schmidt, Kirsten ^a   Jahr, Silke ^a   Huscher, Dörte ^b   Becker, Mike ^a   Riemekasten, Gabriela ^a   Taufmann, Ines ^a   Burmester, Gerd Rüdiger ^a   Pögel, Stephanie ^a   Reisshauer, Anett ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Rheumatism Research Centre   (Germany)

Author keywords

Biofeedback; Deep oscillation; Physiotherapy; Raynaud's phenomenon; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP OSCILLATION; FEEDBACK SYSTEM; FEMALE; HUMAN; INTERVENTION STUDY; MALE; OSCILLATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SCORING SYSTEM; SYSTEMIC SCLEROSIS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR DISEASE; VISUAL ANALOG SCALE;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOFEEDBACK, PSYCHOLOGY; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HUMANS; LINEAR MODELS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863631466     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1882-2     Document Type: Article

References (9)

1. LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22(4):675-694
2. Sunderkotter C, Riemekasten G (2006) Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii33-iii35
3. Riemekasten G, Sunderkotter C (2006) Vasoactive therapies in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 3):iii49-iii51
4. Foerster J, Fleischanderl S, Wittstock S, Storch A, Meffert H, Riemekasten G, Worm M (2005) Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud's phenomenon. J Invest Dermatol 125(6):1313-1316
5. Jahr S, Schoppe B, Reisshauer A (2008) Effect of treatment with low-intensity and extremely low-frequency electrostatic fields (Deep Oscillation) on breast tissue and pain in patients with secondary breast lymphoedema. J Rehabil Med 40(8):645-650
6. Yocum DE, Hodes R, Sundstrom WR, Cleeland CS (1985) Use of biofeedback training in treatment of Raynaud's disease and phenomenon. J Rheumatol 12(1):90-93
7. Wilson E, Belar CD, Panush RS, Ettinger MP (1983) Marked digital skin temperature increase mediated by thermal biofeedback in advanced scleroderma. J Rheumatol 10(1):167-168
8. Freedman RR, Ianni P, Wenig P (1984) Behavioral treatment of Raynaud's phenomenon in scleroderma. J Behav Med 7(4):343-353
9. Malenfant D, Catton M, Pope JE (2009) The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis. Rheumatology (Oxford) 48(7):791-795 Epub 2009 May 11